Walleye Trading’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,420
Closed -$94.7K 4384
2026
Q1
$94.7K Buy
+3,420
New +$87.9K ﹤0.01% 3478
2024
Q1
Sell
-39,752
Closed -$446K 5249
2023
Q4
$446K Buy
+39,752
New +$387K ﹤0.01% 3175

Other funds holding ROIV

Walleye Trading's ROIV Position: Q2 2026 in Review

Walleye Trading sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 3,420 shares — an estimated $94.7K sold.

Walleye Trading first reported a position in ROIV in Q4 2023 and held it in 2 quarters. The position peaked at $446K in Q4 2023. 235 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Walleye Trading reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 3,420 Roivant Sciences shares in Q2 2026, an estimated $94.7K.
  • Walleye Trading first reported a position in Roivant Sciences in Q4 2023 and held it in 2 quarters.
  • Walleye Trading's Roivant Sciences position peaked at $446K in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.